Neumora Therapeutics Appoints Henry Gosebruch as CEO to Lead Neuroscience Revolution

Watertown, MA, July 18, 2023 (Business Wire) -- Neumora Therapeutics, a biopharmaceutical company focused on transforming neuroscience drug development, welcomes Henry Gosebruch as the new President and CEO. With a proven track record in the pharmaceutical industry, most recently as the EVP and Chief Strategy Officer at AbbVie, Gosebruch will drive Neumora's vision of becoming a leader in brain health and pioneering novel therapies for CNS disorders.

Read full article here.